Skip to main content

Table 3 Comparison of outcomes in patients stratified by pre-op MAP and tourniquet use/non-usea

From: The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study

Variable

Pre-op MAP categories

95–110 mmHg

> 110 mmHg

Mean differences (95% CI)

p value

Mean differences (95% CI)

p value

Overall (n = 411)

 Local recurrence b

1.59 (0.84–3.00)

0.150

3.28 (1.26–8.52)

0.015

 Intra-operative hemorrhage volume (mL)

89.9 (−15.5–195.2)

0.108

232.3 (50.9–413.7)

0.009

 Duration of surgery (min)

5.0 (−1.2–11.2)

0.137

8.6 (−2.1–19.2)

0.139

 Intra-operative hemorrhage velocity (mL/min)

0.47 (−0.52–1.46)

0.490

1.39 (−0.31–3.09)

0.130

Tourniquet use (n = 255)

 Local recurrence b

0.77 (0.32–1.86)

0.564

0.59 (0.07–5.07)

0.629

 Intra-operative hemorrhage volume (mL)

6.7 (−5.2–18.7)

0.366

3.1 (−17.6–23.8)

0.928

 Duration of surgery (min)

0.1 (−7.2–7.3)

1.00

3.8 (−8.7–16.2)

0.742

 Intra-operative hemorrhage velocity (mL/min)

0.16 (−0.05–0.37)

0.178

0.01 (−0.37–0.36)

0.999

Tourniquet non-use (n = 156)

 Local recurrence b

4.13 (1.42–12.03)

0.009

28.06 (5.27–149.30)

< 0.001

 Intra-operative hemorrhage vol (mL)

271.8 (188.8–354.8)

< 0.001

628.9 (486.4–771.5)

< 0.001

 Duration of surgery (min)

14.3 (5.2–23.3)

0.001

16.9 (1.3–32.5)

0.031

 Intra-operative hemorrhage velocity (mL/min)

1.38 (0.27–2.50)

0.011

3.88 (1.97–5.80)

< 0.001

  1. aIntra-operative hemorrhage volume, surgical duration, and intra-operative hemorrhage velocity are presented as mean differences (95% CI) compared to the group having < 95 mmHg pre-op MAP
  2. bLocal recurrence was presented as adjusted OR (95% CI) with reference to the group having < 95 mmHg pre-op MAP
  3. Intra-operative hemorrhage velocity = intra-operative hemorrhage volume/surgical duration; pre-op MAP Preoperative mean arterial pressure; OR Odds ratio, CI Confidence interval